Revenue*
R4 211 million
June 2024: R4 323 million
* Excludes discontinued operations
Headline earnings per share
11.68 cents
June 2024: 19.00 cents
Headline earnings
R98.2 million
June 2024: R157.8 million
Earnings per share
11.54 cents
June 2024: Loss per share (14.26) cents
B-BBEE rating
Level 1
Commentary
Introduction and review
AfroCentric “ACT” is a Level 1 B-BBEE JSE listed investment holding company, committed to transforming and advancing healthcare access and affordability across Southern Africa. Through our diversified portfolio of subsidiaries, we deliver integrated health management solutions, including medical aid administration, managed care, medicine provision, wellness services and digital health innovations.
The Group plays a pivotal role across the public and private sectors, driving efficiencies, health outcomes and enabling sustainable healthcare delivery. Our strategic focus remains on expanding our footprint, leveraging technology and clinical innovation and fostering partnerships that support inclusive, value-based healthcare for all.
Downloads
PDF downloads 